BW

Industrial Outdoor Storage Platform, Catalyst Investment Partners, Closes $100 Million Acquisition Credit Facility with U.S. Based Bank

The facility will provide significant capital for Catalyst to continue growing its Industrial Outdoor Storage (“IOS”) portfolio. NEW YORK--(BUSINESS WIRE)--Catalyst Investment Partners has closed on a $100 million acquisition credit facility with a large U.S.-based bank. The facility will provide the company with significant capital to continue growing its portfolio…
Leer más...

The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Affirm Holdings, Inc. (AFRM) Investors

Investors with losses exceeding $250,000 are encouraged to contact the firm LOS ANGELES--(BUSINESS WIRE)--$STOCKS--The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired Affirm Holdings, Inc. (“Affirm” or the “Company”) (NASDAQ: AFRM) securities…
Leer más...

La Opinión Recognized by the National Association of Hispanic Publications Awards 2022

Los Angeles’ Leading Spanish-language Daily Newspaper Wins Multiple Awards at the NAHP Awards LOS ANGELES--(BUSINESS WIRE)--La Opinión, Los Angeles’s leading Spanish-language news source and daily newspaper, was recognized for its achievements in print and digital media by the National Association of Hispanic Publications. The annual awards ceremony celebrates the best…
Leer más...

The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of F45 Training Holdings Inc. (FXLV) Investors

LOS ANGELES--(BUSINESS WIRE)--$STOCKS--The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired F45 Training Holdings Inc. (“F45” or the “Company”) (NYSE: FXLV) common stock pursuant and/or traceable to the Company’s Registration Statement and…
Leer más...

Nomitri Selects Verimatrix XTD to Protect Innovative Cashierless Checkout for Cart-Mounted Smartphones

Unique smartcart and checkout AI technologies reinforced with self-defending cybersecurity technologies that provide multiple layers of defense and detection of security blind spots AIX-EN-PROVENCE, France & SAN DIEGO--(BUSINESS WIRE)--Regulatory News: Verimatrix, (Euronext Paris: VMX) (Paris:VMX), the leader in powering the modern connected world with people-centered security, today announced that Berlin,…
Leer más...

Newman Ferrara LLP Announces Corporate Governance Investigations of Instil Bio, Inc. (TIL)

NEW YORK--(BUSINESS WIRE)--$TIL #NYTop100--Newman Ferrara LLP announced today that the firm is conducting investigations on behalf of shareholders of Instil Bio, Inc. (NASDAQ:TIL) (“Instil” or the “Company”). The investigations concern whether certain of the Instil’s officers and directors breached their fiduciary duties to shareholders, by, among other things: (i) engaging…
Leer más...

Newman Ferrara LLP Announces Corporate Governance Investigations of Sensei Biotherapeutics, Inc. (SNSE)

NEW YORK--(BUSINESS WIRE)--$CME #NYTop100--Newman Ferrara LLP announced today that the firm is conducting investigations on behalf of shareholders of Sensei Biotherapeutics, Inc. (NASDAQ:SNSE) (“Sensei” or the “Company”). The investigations concern whether certain of the Sensei’s officers and directors breached their fiduciary duties to shareholders, by, among other things: (i) engaging…
Leer más...

Compucom Names Kevin Shank Chief Executive Officer

Shank returns to lead company after previous stint in senior leadership FORT MILL, S.C.--(BUSINESS WIRE)--Compucom, a leading managed IT services provider, announced Kevin Shank as its new Chief Executive Officer. Shank returns to lead Compucom after having served as a senior executive at the company from 2005-2014. Shank is a…
Leer más...

Orca Bio Presents Encouraging Interim Clinical Data on Orca-Q in Haploidentical Allogeneic Hematopoietic Stem Cell Transplants at 64th ASH Annual Meeting

– Orca-Q is Orca Bio’s investigational high-precision cell therapy designed to overcome the challenges of haploidentical allogeneic hematopoietic stem cell transplant (alloHSCT) – – Interim multi-center Phase 1 clinical trial results show that Orca-Q improved graft-versus-host disease-free, relapse-free survival in haploidentical alloHSCT compared to standard of care, without use of…
Leer más...